These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24236917)

  • 1. Patents and the US FDA's definition of 'cocrystal': an ordinary and customary meaning?
    Lindeman JA
    Pharm Pat Anal; 2012 Nov; 1(5):513-5. PubMed ID: 24236917
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmaceutical trademarks: navigating through the FDA's pilot program.
    Ferrer E
    Drug News Perspect; 2010 Jun; 23(5):333-6. PubMed ID: 20603657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
    Basile EM; Tolomeo D; Gluck E
    Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA's role in administering the Hatch-Waxman Act.
    Malkin BJ
    Food Drug Law J; 1999; 54(2):211-4. PubMed ID: 11758575
    [No Abstract]   [Full Text] [Related]  

  • 5. Forensic labs warn of deuterated drug threat.
    Sanderson K
    Nature; 2009 Apr; 458(7240):817. PubMed ID: 19369996
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA's role in making exclusivity determinations.
    Dickinson EH
    Food Drug Law J; 1999; 54(2):195-203. PubMed ID: 11758573
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA's biomedical research program.
    Kelsey FO
    J Parenter Drug Assoc; 1980; 34(2):134-8. PubMed ID: 6989974
    [No Abstract]   [Full Text] [Related]  

  • 8. Court is asked to invalidate the Food and Drug Administration's (FDA's) "pediatric rule".
    Maloney DM
    Hum Res Rep; 2002 Dec; 17(12):8. PubMed ID: 12731500
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA's classification of new drugs.
    Schneiweiss F
    N Engl J Med; 1980 Jun; 302(24):1368-9. PubMed ID: 7374693
    [No Abstract]   [Full Text] [Related]  

  • 10. The FDA's new drug rating system.
    Ohio Med; 1991 Mar; 87(3):133-4. PubMed ID: 2030884
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA's Bioresearch Monitoring Program.
    Kelsey FO
    Methods Find Exp Clin Pharmacol; 1982; 4(7):503-8. PubMed ID: 7169836
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA's safety reform is greeted with scepticism.
    Moynihan R
    BMJ; 2005 Feb; 330(7489):435. PubMed ID: 15731128
    [No Abstract]   [Full Text] [Related]  

  • 13. The FDA's classification system for new drugs. An evaluation of therapeutic gain.
    Finkel MJ
    N Engl J Med; 1980 Jan; 302(3):181-3. PubMed ID: 7350458
    [No Abstract]   [Full Text] [Related]  

  • 14. The A to Z of pharmaceutical cocrystals: a decade of fast-moving new science and patents.
    Almarsson Ö; Peterson ML; Zaworotko M
    Pharm Pat Anal; 2012 Jul; 1(3):313-27. PubMed ID: 24236844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of pharmaceutical cocrystals as intellectual property.
    Trask AV
    Mol Pharm; 2007; 4(3):301-9. PubMed ID: 17477544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDA's response to FDA's "Guideline on sterile drug products produced by aseptic processing".
    Akers JE; Agalloco JP; Carleton FJ; Korczynski MS
    J Parenter Sci Technol; 1988; 42(4):114-7. PubMed ID: 3183865
    [No Abstract]   [Full Text] [Related]  

  • 17. Understanding the FDA's guarded system for classifying new drugs.
    Schneiweiss F
    Hosp Pharm; 1979 May; 14(5):262-4, 266, 268 passim. PubMed ID: 10316828
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug development and patent law.
    Nusbaum NJ
    N Y State J Med; 1992 Mar; 92(3):86-7. PubMed ID: 1557205
    [No Abstract]   [Full Text] [Related]  

  • 19. Change in FDA definition of serious adverse drug event.
    Bader RL
    Am J Hosp Pharm; 1989 Jun; 46(6):1132. PubMed ID: 2750762
    [No Abstract]   [Full Text] [Related]  

  • 20. The FDA's enforcement of IRBs and patient informed consent.
    Kelsey FO
    Food Drug Cosmet Law J; 1989 Jan; 44(1):13-20. PubMed ID: 11651627
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.